glp-1 drugs mechanism of action Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Consensus Recommendations on GLP-1 RA
Description
"Comparative Analysis of GLP-1 Receptor Agonists in Weight Management." International Journal of Obesity Research, 2023
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes a meta-analysis
In recent years, its popularity has exploded, and some people use it off-label for weight loss
47.Powell-Wiley TM, Poirier P, Burke LE, Desprs JP, Gordon-Larsen P, Lavie CJ, et al
Notably, weight reduction had not plateaued by 52 weeks, indicating potential for further loss with longer use
doi: 10.1111/bph.15677
